Exelixis, Inc. (EXEL)
43.68
-0.78
(-1.75%)
USD |
NASDAQ |
May 01, 16:00
43.68
0.00 (0.00%)
After-Hours: 19:51
Exelixis Profit Margin (Quarterly) : 40.85% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | -26.05% |
| Bristol Myers Squibb Co. | 23.31% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Pfizer Inc. | -9.34% |
| Madrigal Pharmaceuticals, Inc. | -18.24% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 36.46% |
| Return on Assets | 27.54% |
| Return on Invested Capital | 33.47% |
| Gross Profit Margin (Quarterly) | 95.58% |
| Operating Margin (Quarterly) | 39.41% |
| Return on Net Operating Assets | 142.1% |